141/1507US=23-F / Câncer
Sève P, Mackey JR. Disseminated carcinoma of unknown primary site: detection with f-fluorodeoxyglucose-positron emission tomography. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods, overviews, head and neck cancer, and thyroid cancer. New York: Springer, 2010. p. 59-71. ISBN 978-90-481-3185-3.

CARCINOMA PRIMARIO; DETECCAO COM F-FLUORODESOXIGLICOSE-TOMOGRAFIA


142/1507US=23-F / Câncer
Yasuda I. Unknown lymphadenopathy: diagnosing using an endoscopic ultrasound-guided fine-needle aspiration biopsy. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods, overviews, head and neck cancer, and thyroid cancer. New York: Springer, 2010. p. 73-8. ISBN 978-90-481-3185-3.

LINFADENOPATIA DESCONHECIDO; ENDOSCOPICA ASPIRACAO COM AGULHA FINA BIOPSIA


143/1507US=23-E / Câncer
Dowdy SC, Cliby WA. Advanced ovarian cancer: prediction of surgical outcomes using computed tomograpy. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: ovarian cancer, renal cancer, urogenitary cancer, urinary bladder cancer, cervical uterine cancer, skin cancer, leukemia, multiple myeloma and sarcoma. New York: Springer, 2010. p. 93-103. ISBN 978-90-481-2917-1.

CANCER DE OVARIO AVANCADO; RESULTADOS CIRURGICOS; CITORREDUCAO


144/1507US=23-F / Câncer
Papi S, Grana CM, Bartolomei M, Ravasi L, Cremonesi M, Ferrari M, Martano L, Garaboldi L, Chinol M, Paganelli G. Pretargeted radioimmunotherapy in cancer: an overview. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods, overviews, head and neck cancer, and thyroid cancer. New York: Springer, 2010. p. 81-98. ISBN 978-90-481-3185-3.

RADIOIMUNOTERAPIA; RADIOIMUNOTERAPIA PRETARGETED NO CANCER


145/1507US=23-E / Câncer
Merkle EM, Nelson RC, Lewin JS. Renal cell carcinoma: follow-up with magnetic resonance imaging after percutaneous radiofrequency ablation. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: ovarian cancer, renal cancer, urogenitary cancer, urinary bladder cancer, cervical uterine cancer, skin cancer, leukemia, multiple myeloma and sarcoma. New York: Springer, 2010. p. 109-13. ISBN 978-90-481-2917-1.

CARCINOMA DE CELULAS RENAIS; RESSONANCIA MAGNETICA APOS ABLACAO; RADIOFREQUENCIA PERCUTANEA; TUMOR RESIDUAL OU RECORRENTE


146/1507US=23-F / Câncer
Park SB, Kiernan MC. Chemotherapy-induced neurotoxicity. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods, overviews, head and neck cancer, and thyroid cancer. New York: Springer, 2010. p. 99-119. ISBN 978-90-481-3185-3.

NEUROTOXICIDADE INDUZIDA POR QUIMIOTERAPIA


147/1507US=23-F / Câncer
Yague E, Raguz S. Multidrug resistance. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods, overviews, head and neck cancer, and thyroid cancer. New York: Springer, 2010. p. 121-33. ISBN 978-90-481-3185-3.

RESISTENCIA A MULTIPLAS DROGAS; QUIMIOTERAPIA TRADICIONAL; CANCER DE CELULAS-TRONCO. RESISTENCIA AS DROGAS


148/1507US=23-E / Câncer
Quan JR WDY, Quan FM. Metastatic kidney cancer: treatment with infusional interleukin-2 plus famotidine. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: ovarian cancer, renal cancer, urogenitary cancer, urinary bladder cancer, cervical uterine cancer, skin cancer, leukemia, multiple myeloma and sarcoma. New York: Springer, 2010. p. 115-20. ISBN 978-90-481-2917-1.

CANCER RENAL METASTATICO; TRATAMENTO COM INFUSAO DE INTERLEUCINA-2


149/1507US=23-E / Câncer
Klatte T, Böhm M. Renal cell carcinoma: preoperative treatment with cytokines followed by surgery. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: ovarian cancer, renal cancer, urogenitary cancer, urinary bladder cancer, cervical uterine cancer, skin cancer, leukemia, multiple myeloma and sarcoma. New York: Springer, 2010. p. 121-35. ISBN 978-90-481-2917-1.

CARCINOMA DE CELULAS RENAIS; TRATAMENTO PRE-OPERATORIO COM CITOCINAS


150/1507US=23-E / Câncer
Tomita Y, Maruyama R, Itoi T, Bilim V. Metastatic renal cell carcinoma: use of Bcl-2 and Fas to predict responses to immunotherapy. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: ovarian cancer, renal cancer, urogenitary cancer, urinary bladder cancer, cervical uterine cancer, skin cancer, leukemia, multiple myeloma and sarcoma. New York: Springer, 2010. p. 137-45. ISBN 978-90-481-2917-1.

CARCINOMA; METASTATICO DE CELULAS RENAIS; BCL-2 E FAS; IMUNOTERAPIA


151/1507US=23-E / Câncer
Ozluk Y. Wilms tumor: prognosis using microvessel density. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: ovarian cancer, renal cancer, urogenitary cancer, urinary bladder cancer, cervical uterine cancer, skin cancer, leukemia, multiple myeloma and sarcoma. New York: Springer, 2010. p. 147-55. ISBN 978-90-481-2917-1.

TUMOR DE WILMS; DENSIDADE MICROVASCULAR. PROGNOSTICO; ANGIOGENESE


152/1507US=23-E / Câncer
Burel-Vandenbos F, Cardot-Leccia N, Haudebourg J, Ambrosetti D, Michiels JF. Adenomatoid tumor of the adrenal gland: differential diagnosis using immunohistochemistry. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: ovarian cancer, renal cancer, urogenitary cancer, urinary bladder cancer, cervical uterine cancer, skin cancer, leukemia, multiple myeloma and sarcoma. New York: Springer, 2010. p. 161-65. ISBN 978-90-481-2917-1.

TUMOR ADENOMATOIDE DA GLANDULA SUPRA-RENAL; DIAGNOSTICO COM IMUNOISTOQUIMICA; IMUNOFENOTIPO


153/1507US=23-E / Câncer
Spiess PE, Tannir NM, Pisters LL. Testicular cancer: post-chemotherapy retroperitoneal lymph node dissection. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: ovarian cancer, renal cancer, urogenitary cancer, urinary bladder cancer, cervical uterine cancer, skin cancer, leukemia, multiple myeloma and sarcoma. New York: Springer, 2010. p. 167-79. ISBN 978-90-481-2917-1.

CANCER DE TESTICULO; POS-QUIMIOTERAPIA; RETROPERITONEAL DISSECCAO DE LINFONODOS


154/1507US=23-E / Câncer
Richiardi L, Maule MM. Survivors of germ-cell testicular cancer: increased risk of second primary tumors. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: ovarian cancer, renal cancer, urogenitary cancer, urinary bladder cancer, cervical uterine cancer, skin cancer, leukemia, multiple myeloma and sarcoma. New York: Springer, 2010. p. 181-91. ISBN 978-90-481-2917-1.

GERMES; CELULAS DE CANCER TESTICULAR; TUMOR PRIMARIO


155/1507US=23-E / Câncer
Svatek RS, Lotan Y. Urothelial bladder cancer: screening with urine-based tumor markers. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: ovarian cancer, renal cancer, urogenitary cancer, urinary bladder cancer, cervical uterine cancer, skin cancer, leukemia, multiple myeloma and sarcoma. New York: Springer, 2010. p. 197-209. ISBN 978-90-481-2917-1.

CANCER DE BEXIGA UROTELIAL; TRIAGEM HEMATURIA; URINA BASEADO MARCADORES TUMORAIS


156/1507US=23-E / Câncer
Mowla SJ, Jafarnejad SM, Atlasi Y. Detection of OCT-4 in bladder cancer: role of cancer stem cell. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: ovarian cancer, renal cancer, urogenitary cancer, urinary bladder cancer, cervical uterine cancer, skin cancer, leukemia, multiple myeloma and sarcoma. New York: Springer, 2010. p. 211-26. ISBN 978-90-481-2917-1.

DETECCAO DE OCT-4; CANCER DE BEXIGA; PAPEL DE CELULA-TRONCO DO CANCER


157/1507US=23-E / Câncer
Baker AC, Grizzle WE, Chhieng D. Uterine cervical glandular lesions: differentiation using immunohistochemistry of mucins. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: ovarian cancer, renal cancer, urogenitary cancer, urinary bladder cancer, cervical uterine cancer, skin cancer, leukemia, multiple myeloma and sarcoma. New York: Springer, 2010. p. 231-42. ISBN 978-90-481-2917-1.

CERVICO-UTERINO; LESOES GLANDULARES; IMUNOHISTOQUIMICA DAS MUCINAS


158/1507US=23-E / Câncer
Baker AC, Grizzle WE, Chhieng D. Uterine cervical glandular lesions: differentiation using immunohistochemistry of mucins. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: ovarian cancer, renal cancer, urogenitary cancer, urinary bladder cancer, cervical uterine cancer, skin cancer, leukemia, multiple myeloma and sarcoma. New York: Springer, 2010. p. 243-53. ISBN 978-90-481-2917-1.

CERVICO-UTERINO; LESOES GLANDULARES; IMUNOHISTOQUIMICA DE MUCINAS


159/1507US=23-E / Câncer
Kato S, Ohno T. Cancer imaging and intracavitary brachytherapy for cervical cancer. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: ovarian cancer, renal cancer, urogenitary cancer, urinary bladder cancer, cervical uterine cancer, skin cancer, leukemia, multiple myeloma and sarcoma. New York: Springer, 2010. p. 257-62. ISBN 978-90-481-2917-1.

CANCER DE IMAGEM; BRAQUITERAPIA INTRACAVITARIA; CANCER CERVICAL


160/1507US=23-E / Câncer
Greimel E. Cervical cancer: methods for assessing the quality of life. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: ovarian cancer, renal cancer, urogenitary cancer, urinary bladder cancer, cervical uterine cancer, skin cancer, leukemia, multiple myeloma and sarcoma. New York: Springer, 2010. p. 263-73. ISBN 978-90-481-2917-1.

CANCER DE COLO UTERINO; CANCER DE COLO UTERINO. QUALIDADE DE VIDA


Primeira | Anterior | Próxima | Última